|Videos|July 25, 2016

Minimizing the Risk of Infection Transmission from Animal-assisted Therapies in Healthcare Setting

Gonzalo Bearman, MD, MPH, hospital epidemiologist, Virginia Commonwealth University, describes possible protocols that healthcare institutions can implement in order to reduce the risk of animal to human infection transmission.

Gonzalo Bearman, MD, MPH, hospital epidemiologist, Virginia Commonwealth University, describes possible protocols that healthcare institutions can implement in order to reduce the risk of animal to human infection transmission.

Interview Transcript (slightly modified for readability)

“I think the strategies to minimize the risk of [infection transmission from] animal-assisted therapies can be thought of in several ways. Number one, are administrative controls: having a program that’s formal, that’s protocolized, and under the supervision of the volunteer services of the hospital in conjunction with [an] infection prevention group, or the infectious disease service. That’s element number one.

The other element in administrative controls is avoiding visits to areas of highest risk, like bone marrow transplant units, [Intensive Care Units (ICUs)], kitchens, burn units.

Another [way to avoid infection transmission] is to train the handler. The handler of the animal knows how to read their dog’s emotions, how to keep the dog properly calm, make sure it doesn’t stray from the leash. [The handler] knows how to respond in the event that there is something such as a urination, or a fecal incident in the hospital; the trainers know how to manage that.

Last, but not least, is the actual animal itself. That animal should have certifications from a qualified veterinarian, of being in good health, and that the animal is up-to-date on vaccines, also. Another component of the protocolized visits is before the visit, the animal’s nails should be trimmed so that they don’t pose a risk [of] scratching. Another [thing] is that the fur should combed through, to remove any excess fur, any excess danders, and also to look for any ectoparasites, like ticks and fleas, and if those are present, then certainly the animal shouldn’t be allowed in the healthcare setting. Last, is actually bathing the animal prior to the visit, either the night before or the day of the visit, so that the animal comes as clean as possible to the time of the actual animal-assisted therapy visit.

So those are kind of the broad strokes [of] how you can really minimize [the] risk across the healthcare setting with animal visits.”


Related to this article

Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.